Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
04/27/2005 | CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone |
04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
04/27/2005 | CN1198795C N-acyl amino-acid amide prodn. process |
04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
04/27/2005 | CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina |
04/26/2005 | US6884803 Phenylalkynes |
04/21/2005 | WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
04/21/2005 | WO2005035499A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
04/21/2005 | WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
04/21/2005 | WO2004062601A3 Antibacterial agents |
04/21/2005 | US20050085636 Reacting organoboron compound with oxypiperidine compound |
04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
04/21/2005 | US20050085516 2-W-diaminocarboxylic acid compounds |
04/21/2005 | US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors |
04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
04/21/2005 | US20050085506 Novel gamma secretase inhibitors |
04/21/2005 | US20050085474 difluoroamine compounds |
04/21/2005 | US20050085456 Compounds useful in therapy |
04/21/2005 | CA2541831A1 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
04/20/2005 | EP1524266A1 Pharmaceutical composition |
04/20/2005 | EP1524265A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors |
04/20/2005 | EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
04/20/2005 | EP1210330B1 Antibacterial agents |
04/20/2005 | EP0721455B9 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
04/20/2005 | CN1608051A Method of resolving amlodipine racemate |
04/20/2005 | CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
04/19/2005 | US6881845 Reacting p-fluoroacetophenone with formaldehyde and methylbenzylamine, then hydrogenation, cyclization and reducing to form chemical intermediates for paroxetine and omiloxetine |
04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
04/19/2005 | CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
04/14/2005 | WO2005034184A2 Lighting elements, devices and methods |
04/14/2005 | WO2005033288A2 Hedgehog pathway antagonists |
04/14/2005 | WO2005033064A1 Process of preparing o-carbamoyl compounds in the presence of active amine group |
04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
04/14/2005 | WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors |
04/14/2005 | WO2005032479A2 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
04/14/2005 | WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
04/14/2005 | WO2005000815A3 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
04/14/2005 | US20050080268 Process of preparing O-carbamoyl compounds in the presence of active amine group |
04/14/2005 | US20050080265 Sleep disorders; side effect reduction |
04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
04/14/2005 | US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission |
04/14/2005 | US20050080088 Novel compounds |
04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
04/14/2005 | US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders) |
04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
04/14/2005 | US20050079455 Colour photographic recording material |
04/14/2005 | CA2541303A1 Process of preparing o-carbamoyl compounds in the presence of active amine group |
04/13/2005 | EP1522314A1 Remedies for diseases caused by vascular contraction or dilation |
04/13/2005 | EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
04/13/2005 | EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent |
04/13/2005 | CN1606592A Novel flame retarding compounds |
04/13/2005 | CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
04/13/2005 | CN1606442A Treatments for restless legs syndrome |
04/13/2005 | CN1196684C Process for producing N.N'-carbonyl dilactan |
04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
04/12/2005 | US6878736 Histamine H3 receptor ligands |
04/12/2005 | US6878725 Serine protease inhibitors |
04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
04/12/2005 | US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
04/12/2005 | CA2293247C 4-phenylpiperidine compounds |
04/12/2005 | CA2279817C Process for the preparation of substituted piperidine-epoxides |
04/12/2005 | CA2148421C Process for producing optically pure 1,4-dihydropyridines |
04/12/2005 | CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives |
04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
04/07/2005 | WO2005030751A2 Dipeptidyl peptidase inhibitors |
04/07/2005 | WO2005030722A1 N-substituted-n-(4-piperidinyl) amide derivative |
04/07/2005 | WO2005030721A1 Piperidine derivative |
04/07/2005 | WO2005030720A1 Piperidine derivative having nmda receptor antagonistic activity |
04/07/2005 | WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces |
04/07/2005 | WO2005000845A3 Bicyclic derivatives as nk-1 and nk-2 antagonists |
04/07/2005 | WO2004113289A3 Glycosidase inhibitors and methods of synthesizing same |
04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
04/07/2005 | US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity |
04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
04/07/2005 | US20050075344 Melanocortin receptor agonists |
04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
04/07/2005 | US20050075320 Gamma-secretase inhibitors |
04/07/2005 | US20050075270 Process for preparation of piperidin-2-ylacetic acid |
04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
04/06/2005 | EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
04/06/2005 | EP1414817B1 substituted isoindoles and the use thereof |
04/06/2005 | EP1212486B1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |